Health
Moderna COVID-19 vaccine well-tolerated, generates immune response in older adults: Study – The Indian Express
The study, published in the New England Journal of Medicine, noted that the experimental vaccine, mRNA-1273, was well-tolerated by the older trial participants,…
By: AP | Boston |
Updated: September 30, 2020 7:40:28 pm
According to the researchers from NIAID, older adults are more vulnerable to complications of COVID-19, and are an important population for vaccination. (AP/File)Results from the Phase 1 trial of an investigational COVID-19 vaccine co-developed by researchers at the US National Institute of Allergy and Infectious Diseases (NIAID), and the American biotech company Moderna have shown that it is well-tolerated and generates a strong immune…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Business19 hours agoASX 200 plunges as US tariffs fall-out continues
-
Noosa News19 hours agoPolice to get on-the-spot protection powers for DV victims
-
Noosa News15 hours agoBrisbane Doctor jailed for supplying drugs worth millions to bikies